Kidney Cancer Research Network of Canada consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized controlled trials

INTRODUCTION: The Kidney Cancer Research Network of Canada (KCRNC) collaborated to prepare this consensus statement about the use of target agents as adjuvant therapy in patients with non-metastatic renal cell carcinoma (nmRCC) after nephrectomy. We reviewed the published data and performed a meta-a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can Urol Assoc J
Autors principals: Karakiewicz, Pierre I., Zaffuto, Emanuele, Kapoor, Anil, Basappa, Naveen S., Bjarnason, Georg A., Blais, Normand, Breau, Rodney H., Canil, Christina, Drachenberg, Darrel, Hotte, Sebastien J., Jeldres, Claudio, Jewett, Michael A.S., Kassouf, Wassim, Kollmannsberger, Christian, Lavallée, Luke T., Maloni, Ranjena, Patenaude, Francois, Pouliot, Frédéric, Reaume, M. Neil, Sabbagh, Robert, Shayegan, Bobby, So, Alan, Soulières, Denis, Tanguay, Simon, Wood, Lori, Bandini, Marco
Format: Artigo
Idioma:Inglês
Publicat: Canadian Medical Association 2018
Matèries:
Consensus Statement
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5994982/
https://ncbi.nlm.nih.gov/pubmed/29877179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.5187
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars